In 2019, regulatory updates from the FDA prompted our engineering team to revisit the foundational technology behind our Gen-1 devices. Through rigorous research, we developed a new proprietary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback